This is Crazy!!! While unlikely to pose any significant issues the arrival of another new variant still demonstrates that we're still in this for a long while yet???
https://www.nj.com/coronavirus/2022/01/new-covid-variant-called-ihu-discovered-in-france-what-is-known-so-far.html
As such ScreenPro continues to have relevance as is for at least all of 2022. Not only should this increase the coffers but that revenue (and profits) should provide both capital and time to consider strategic moves and acquisitions that can see them move deeper into the world of virtual and personal medicine.
For example the covid tests currently being manufactured through the connections in South Korea could pivot to include covid, the flu, vitamin deficiencies etc. If visiting the doctor is going to be reduced to telephone or online face to face conversations there could very well be a market for self testing like that for diabetics.
As a company with annual revenues closing in on $20 million, a second year of the same or better provides a tremendous level of upside.